Editorial, Arcr Vol: 14 Issue: 1

MicroRNAs in Cardiology: Small Molecules with Big Impact

Ananya Iyer^*

Department of Emergency & Trauma, JIPMER, Puducherry, India

*Corresponding Author:

Ananya Iyer
Department of Emergency & Trauma, JIPMER, Puducherry, India
E-mail: ananya.iyer@jipmer.edu.in

Received: 01-March-2025, Manuscript No. arcr-25-169176; Editor assigned: 4-March-2025, Pre-QC No. arcr-25-169176 (PQ); Reviewed: 20-March-2025, QC No arcr-25-169176; Revised: 26-March-2025, Manuscript No. arcr-25- 169176 (R); Published: 30-March-2025, DOI: 10.4172/2324-903X.1000129

Citation: Ananya I (2025) MicroRNAs in Cardiology: Small Molecules with Big Impact. Analg Resusc: Curr Res 14:129

Introduction

MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules approximately 20–22 nucleotides in length that regulate gene expression post-transcriptionally. Since their discovery, miRNAs have emerged as pivotal regulators of various physiological and pathological processes, including cardiovascular function. In cardiology [1], miRNAs influence heart development, function, and the progression of diseases such as myocardial infarction, heart failure, arrhythmias, and atherosclerosis. Their unique roles make them promising biomarkers and therapeutic targets in cardiovascular medicine [2].

Role of MicroRNAs in Cardiovascular Biology

MicroRNAs regulate gene expression by binding to complementary sequences on target messenger RNAs (mRNAs), leading to mRNA degradation or translational repression. This fine-tuning mechanism allows miRNAs to orchestrate complex gene networks critical for cardiac cell differentiation, growth, and survival. During cardiac development, specific miRNAs control the proliferation and differentiation of cardiac progenitor cells, ensuring proper formation of the heart. In adult hearts, miRNAs maintain cellular homeostasis and adapt responses to stress [3].

In pathological states, altered miRNA expression profiles have been associated with various cardiovascular diseases:

• Myocardial infarction (MI): Certain miRNAs are upregulated in response to ischemic injury, modulating apoptosis, inflammation, and fibrosis [4].
• Heart failure: Dysregulated miRNAs contribute to maladaptive remodeling and impaired contractility.
• Arrhythmias: MiRNAs affect ion channel expression and electrical conduction properties.
• Atherosclerosis: MiRNAs regulate endothelial function, lipid metabolism, and inflammatory responses involved in plaque formation [5].

Given their stability in circulation and disease-specific expression patterns, circulating miRNAs serve as minimally invasive biomarkers for early diagnosis and prognosis of cardiac conditions.

Therapeutic Potential

Harnessing miRNAs for therapeutic purposes involves strategies to either inhibit overexpressed miRNAs (using antagomirs or miRNA sponges) or restore downregulated miRNAs (using miRNA mimics). Preclinical studies have demonstrated promising results in animal models of heart disease, where modulation of specific miRNAs improved cardiac function and reduced adverse remodeling. Challenges remain in delivery methods, specificity, and safety, but ongoing research continues to advance the potential clinical applications of miRNA-based therapies in cardiology.

Conclusion

MicroRNAs represent a vital layer of genetic regulation in the cardiovascular system, with significant implications for understanding cardiac physiology and pathology. Their roles as biomarkers and therapeutic targets hold great promise for transforming cardiovascular diagnosis and treatment. Continued research into miRNA biology and technology is essential to fully realize their potential in clinical cardiology.

REFERENCES

1. Mujagic S, Kozic D, Huseinagic H, Smajlovic D. Symmetry, asymmetry and hypoplasia of intracranial internal carotid artery on magnetic resonance angiography. Acta Med Acad. 2016; 45:1- 9.

PubMed, Google Scholar, CrossRef

2. Rusu MC, Vrapclu AD, Lazar M. A rare variant of accessory cerebral artery. Surg Radiol Anat. 2023; 45(5):523-526.

PubMed, Google Scholar, CrossRef

3. Krause DA, Youdas JW. Bilateral presence of a variant subscapularis muscle. Int J Anat Var. 2017; 10(4):79-80.

Google Scholar

4. Mann MR, Plutecki D, Janda P, PÄ?kala J, Malinowski K, et al. The subscapularis muscleâ?a metaâ?analysis of its variations, prevalence, and anatomy. Clin Anat. 2023; 36(3):527-541.

PubMed, Google Scholar, CrossRef

5. Pillay M, Jacob SM. Bilateral presence of axillary arch muscle passing through the posterior cord of the brachial plexus. Int. J. Morphol., 27(4):1047-1050, 2009.

PubMed, Google Scholar, CrossRef